US FDA wil kleinere hoeveelheden medicijnen per verpakking

The U.S. Food and Drug Administration is asking manufacturers of a common opioid medicine to change the way the drug is packaged, as part of efforts to deter its abuse amid an opioid epidemic in the United States.
The agency wants to eliminate the large bottles in which loperamide is often sold because the abuse of the drug requires such large quantities. It is also influencing doctors to prescribe shorter-duration opioids. The actions are also part of the agency’s efforts to reduce patients’ exposure to opioids, which killed more than 42,000 Americans in 2016, according to estimates from the Centers for Disease Control and Prevention (Reuters Health News, 30 januari 2018).
Klik hier om het volledige nieuwsbericht te lezen.
Klik hier om het FDA-persbericht hierover te lezen.
Klik hier voor meer informatie over het NVC-project Pharmaceutical Packaging Innovation.
Klik hier voor meer informatie over de Live Online NVC E-Course Pharmaceutical Packaging.

Dit bericht is ook opgenomen in ons maandelijkse nieuwsoverzicht, de NVC Members-only Update. Heeft u vragen, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411.